Photodynamic eradication of amelanotic melanoma of the hamster with fast acting photosensitizers

International Journal of Cancer

Volumn 65, Issue 2, 1996, Pages 246-248

  Dellian, Marc ^a,b   Richert, Clemens ^a,c   Gamarra, Fernando ^a   Goetz, Alwin E ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TUFTS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOTOFRIN; PHOTOSENSITIZING AGENT; PORPHYCENE DERIVATIVE; UNCLASSIFIED DRUG;

AMELANOTIC MELANOMA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; HAMSTER; LASER; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL;

ANIMALS; CRICETINAE; MELANOMA, AMELANOTIC; PHOTOSENSITIZING AGENTS; PHOTOTHERAPY; PORPHYRINS; SKIN NEOPLASMS;

EID: 0030051937     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19960117)65:2<246::AID-IJC19>3.0.CO;2-B     Document Type: Article

References (22)

1. AMATO, I., Hope for a magic bullet that moves at the speed of light. Science, 262, 32-33 (1993).
2. BARR, H., TRALAU, C.J., MACROBERT, A.J., KRASNER, N., BOULOS, P.B., CLARK, C.G. and BOWN, S.G., Photodynamic therapy in the normal rat colon with phthalocyanine sensitisation. Brit. J. Cancer, 56, 111-118 (1987).
3. BRAICHOTTE, D.R., WAGNIERES, G.A., BAYS, R., MONNIER, P. and VAN DEN BERGH, H.E., Clinical pharmacokinetic studies of photofrin by fluorescence spectroscopy in the oral cavity, the esophagus, and the bronchi. Cancer, 75, 2768-2778 (1995).
4. DELLIAN, M., WALENTA, S., GAMARRA, F., KUHNLE, G.E.H., MUELLER-KLIESER, W. and GOETZ, A.E., High-energy shock waves enhance hyperthermic response of tumors: effects on blood flow, energy metabolism and tumor growth. J. nat. Cancer Inst., 86, 287-293 (1994).
5. DOUGHERTY, T.J., COOPER, M.T. and MANG, T.S., Cutaneous phototoxic occurrences in patients receiving Photofrin. Lasers Surg. Med., 10, 485-488 (1990).
6. FERRARIO, A., KESSEL, D. and GOMER, C.J., Metabolic properties and photosensitizing responsiveness of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res., 52, 2890-2893 (1992).
7. FORTNER, J.G., MAHY, A.G. and SCHRODT, G.R., Transplantable tumors of the Syrian (Golden) hamster. Part I: Tumors of the alimentary tract, endocrine glands and melanomas Cancer Res., 21, 161-198 (1961).
8. GOMER, C.J. and FERRARIO, A., Tissue distribution and photosensitizing properties of mono-L-aspartyl chlorin e6 in a mouse tumor model. Cancer Res., 50, 3985-3990 (1990).
9. KESSEL, D. and DOUGHERTY, J., Porphynn photosensitization, Plenum, New York (1983).
10. LEUNIG, M., LEUNIG, A., LANKES, P. and GOETZ, A.E., Evaluation of photodynamic therapy-induced heating of hamster melanoma and its effect on local tumor eradication. Int. J. Hyperthermia, 10, 297-306 (1994).
11. LEUNIG, M., RICHERT, C., GAMARRA, F., LUMPER, W., VOGEL, E., JOCHAM, D. and GOETZ, A.E., Tumour localisation kinetics of photofrin and three synthetic porphyrinoids in an amelanotic melanoma of the hamster. Brit. J. Cancer, 68, 225-234 (1993).
12. LIVINGSTON, R.B. and CARTER, S.K., Experimental design and clinical trials: clinical perspectives. In: S.K. Carter, S.K. Glatstein and R.B. Livingston (eds.), Principles of cancer treatment, pp. 34-45, McGraw-Hill, New York (1982).
13. PASS, H.I., Photodynamic therapy in oncology: mechanisms and clinical use. J. nat. Cancer Inst., 85, 443-456 (1993).
14. RICHERT, C., A long-time-stable liposome formulation for porphyrinoid photosensitizers. J. Photochem. Photobiol. B Biol., 19, 67-69 (1993a).
15. RICHERT, C., Photosensibilisierung von neoplastischem Gewebe mit Porphycenen, Ph.D. Thesis, Ludwig-Maximilians-University, Munich (1993b).
16. RICHERT, C., WESSELS, J.M., MÜLLER, M., KISTERS, M., BENNINGHAUS, T. and GOETZ, A.E., Photodynamic antitumor agents: beta-methoxyethyl groups give access to functionalized porphycenes and enhance cellular uptake and activity. J. med Chem., 37, 2797-2807 (1994).
17. RICHTER, A.M., CERRUTI-SOLA, S., STERNBERG, E.D., DOLPHIN, D. and LEVY, J.G., Biodistribution of tritiated benzoporphyrin derivative (3H-BPD-MA), a new potent photosensitizer, in normal and tumor-bearing mice. J. Photochem. Photobiol. B, 5, 231-244 (1990).
18. RICHTER, A.M., JAIN, A.K., CANAAN, A.J., WATERFIELD, E., STERNBERG, E.D. and LEVY, J.G., Photosensitizing efficiency of two regioisomers of the benzoporphyrin derivative monoacid ring A (BPD-MA). Biochem. Pharmacol., 43, 2349-2358 (1992).
19. SASSY, T., RICHERT, C., BAUMGARTNER, R., JOCHAM, D. and UNSOLD, E., Comparative study of the photodynamic effects of porphycenes and photofrin II on SSK2-fibrosarcoma of mice. Lasers Med. Sci., 7, 255 (1992).
20. TRALAU, C.J., MACROBERT, A.J., COLERIDGE-SMITH, P.D., BARR, H. and BOWN, S.G., Photodynamic therapy with phtalocyanine sensitisation: quantitative studies in a transplantable rat fibrosarcoma. Brit J. Cancer, 55, 389-395 (1987).
21. WEISS, N., DELIUS, M., GAMBIHLER, S., DIRSCHEDL, P., GOETZ, A. and BRENDEL, W., Influence of the shock wave application mode on the growth of A-Mel 3 and SSK2 tumors in vivo. Ultrasound Med. Biol., 16, 595-605 (1990).
22. ZALAR, G.L., POH-FITZPATRICK, M., KROHN, D.L., JAKOBS, R. and HARBER, L.C., Induction of drug photosensitisation in man after parenteral exposure to hematoporphyrin. Arch. Dermatol., 113, 1392-1396 (1977).